223 related articles for article (PubMed ID: 30925939)
1. The diagnostic and prognostic values of plasma Epstein-Barr virus DNA for residual cervical lymphadenopathy in nasopharyngeal carcinoma patients: a retrospective study.
Liu SL; Sun XS; Li XY; Tang LQ; Chen QY; Lin HX; Liang YJ; Yan JJ; Lin C; Guo SS; Liu LT; Li Y; Xie HJ; Tang QN; Liang H; Guo L; Mai HQ
Cancer Commun (Lond); 2019 Mar; 39(1):14. PubMed ID: 30925939
[TBL] [Abstract][Full Text] [Related]
2. Dynamic changes in plasma Epstein-Barr virus DNA load during treatment have prognostic value in nasopharyngeal carcinoma: a retrospective study.
He SS; Wang Y; Bao Y; Cai XY; Yang XL; Chen DM; Chen Y; Lu LX
Cancer Med; 2018 Apr; 7(4):1110-1117. PubMed ID: 29493874
[TBL] [Abstract][Full Text] [Related]
3. The Dynamic Change in Plasma Epstein-Barr Virus DNA Load over a Long-Term Follow-Up Period Predicts Prognosis in Nasopharyngeal Carcinoma.
Gihbid A; Benzeid R; Faouzi A; El Alami I; Tawfiq N; Benchakroun N; Bendahhou K; Benider A; Guensi A; Khaali W; Chaoui I; El Mzibri M; Cadi R; Khyatti M
Viruses; 2022 Dec; 15(1):. PubMed ID: 36680107
[TBL] [Abstract][Full Text] [Related]
4. Clinical value of a plasma Epstein-Barr virus DNA assay in the diagnosis of recurrent or metastatic nasopharyngeal carcinoma: a meta-analysis.
Peng H; Li Z; Long Y; Li J; Liu Z; Zhou R
Biosci Rep; 2019 Sep; 39(9):. PubMed ID: 31484795
[TBL] [Abstract][Full Text] [Related]
5. Epstein-Barr virus DNA level as a novel prognostic factor in nasopharyngeal carcinoma: A meta-analysis.
Zhang J; Shu C; Song Y; Li Q; Huang J; Ma X
Medicine (Baltimore); 2016 Oct; 95(40):e5130. PubMed ID: 27749596
[TBL] [Abstract][Full Text] [Related]
6. Integrating pretreatment MRI-detected nodal features and Epstein-Barr virus DNA to identify optimal candidates for intensity-modulated radiotherapy alone in patients with stage II nasopharyngeal carcinoma.
Guo J; He Y; Lin C; Jiang Q; Xing HW; Zhang YC; Shen GZ; Lin HX; Guo L; Yang Q
Oral Oncol; 2023 Nov; 146():106574. PubMed ID: 37741017
[TBL] [Abstract][Full Text] [Related]
7. Prognostic value of circulating Epstein-Barr virus DNA level post-induction chemotherapy for patients with nasopharyngeal carcinoma: A recursive partitioning risk stratification analysis.
Kong FF; Pan GS; Du CR; Ni MS; Zhai RP; He XY; Shen CY; Lu XG; Hu CS; Ying HM
Radiother Oncol; 2023 Aug; 185():109721. PubMed ID: 37244356
[TBL] [Abstract][Full Text] [Related]
8. A novel and non-invasive approach utilising nasal washings for the detection of nasopharyngeal carcinoma.
Tan GW; Sivanesan VM; Abdul Rahman FI; Hassan F; Hasbullah HH; Ng CC; Khoo AS; Tan LP
Int J Cancer; 2019 Oct; 145(8):2260-2266. PubMed ID: 30698824
[TBL] [Abstract][Full Text] [Related]
9. Residual plasma Epstein-Barr virus DNA after intensity-modulated radiation therapy is associated with poor outcomes in nasopharyngeal carcinoma.
Zhou P; Zhou J; Lian CL; Yu YF; Zhou R; Lin Q; Wu SG
Future Oncol; 2023 Oct; 19(33):2227-2235. PubMed ID: 37909289
[No Abstract] [Full Text] [Related]
10. Prognostic value of p16 expression in Epstein-Barr virus-positive nasopharyngeal carcinomas.
Jiang W; Chamberlain PD; Garden AS; Kim BY; Ma D; Lo EJ; Bell D; Gunn GB; Fuller CD; Rosenthal DI; Beadle BM; Frank SJ; Morrison WH; El-Naggar AK; Glisson BS; Sturgis EM; Phan J
Head Neck; 2016 Apr; 38 Suppl 1(Suppl 1):E1459-66. PubMed ID: 26560893
[TBL] [Abstract][Full Text] [Related]
11. Nasopharyngeal Epstein-Barr virus DNA loads in high-risk nasopharyngeal carcinoma families: Familial aggregation and host heritability.
Zheng MQ; Wang TM; Liao Y; Xue WQ; He YQ; Wu ZY; Yang DW; Li DH; Deng CM; Jia YJ; Yuan LL; Zhang WL; Luo LT; Tong XT; Wu YX; Zhou T; Li XZ; Tang LL; Zhang JB; Xia YF; Mu J; Jia WH
J Med Virol; 2020 Dec; 92(12):3717-3725. PubMed ID: 32558959
[TBL] [Abstract][Full Text] [Related]
12. Nomogram incorporating Epstein-Barr virus DNA and a novel immune-nutritional marker for survival prediction in nasopharyngeal carcinoma.
Wu S; Yuan X; Huang H; Li Y; Cui L; Lin D; Lu W; Feng H; Chen Z; Liu X; Tan J; Wang F
BMC Cancer; 2023 Dec; 23(1):1217. PubMed ID: 38066499
[TBL] [Abstract][Full Text] [Related]
13. Prognostic value of metastatic cervical lymph node stiffness in nasopharyngeal carcinoma: A prospective cohort study.
Sun XS; Wang JW; Han F; Zou RH; Yang ZC; Guo SS; Liu LT; Chen QY; Tang LQ; Mai HQ
Radiother Oncol; 2023 Dec; 189():109939. PubMed ID: 37806561
[TBL] [Abstract][Full Text] [Related]
14. Clinical utility of Epstein-Barr virus DNA and other liquid biopsy markers in nasopharyngeal carcinoma.
Tan R; Phua SKA; Soong YL; Oon LLE; Chan KS; Lucky SS; Mong J; Tan MH; Lim CM
Cancer Commun (Lond); 2020 Nov; 40(11):564-585. PubMed ID: 32989921
[TBL] [Abstract][Full Text] [Related]
15. Study on the value of Inhibin B in the diagnosis of nasopharyngeal carcinoma and its correlation with traditional Chinese medicine syndromes: An observational study.
Ma N; Deng X; Liu Q; Xu F; Guo Q; Yan K; Yang Y; Zou G
Medicine (Baltimore); 2024 Jun; 103(23):e38416. PubMed ID: 38847724
[TBL] [Abstract][Full Text] [Related]
16. Locoregional radiotherapy improves survival outcomes in de novo metastatic nasopharyngeal carcinoma treated with chemoimmunotherapy.
Hu YJ; Lu TZ; Zhang H; Fang M; Chen BJ; Guo QJ; Lin SJ; Feng P; Wang Y; Jiang TC; Gong XC; Pan JJ; Li JG; Xia YF
ESMO Open; 2023 Oct; 8(5):101629. PubMed ID: 37660406
[TBL] [Abstract][Full Text] [Related]
17. Longitudinal post-radiotherapy plasma Epstein-Barr virus DNA trends inform on optimal risk stratification in endemic nasopharyngeal carcinoma.
Neo J; Yip PL; Ong EHW; Miao J; Chow WM; Wee JTS; Fong KW; Soong YL; Tan TWK; Tan JSH; Sin SY; Liu J; Loh KS; Tay JK; Ang MK; Tan SH; Lim DWT; Chua MLK
Oral Oncol; 2024 Jan; 148():106655. PubMed ID: 38056062
[TBL] [Abstract][Full Text] [Related]
18. Matted Lymph Nodes on MRI in Nasopharyngeal Carcinoma: Prognostic Factor and Potential Indication for Induction Chemotherapy Benefits.
Dong A; Zhu S; Ma H; Wei X; Huang W; Ruan G; Liu L; Mo Y; Ai F
J Magn Reson Imaging; 2024 Jun; 59(6):1976-1990. PubMed ID: 37706438
[TBL] [Abstract][Full Text] [Related]
19. Plasma Epstein-Barr Virus DNA and Risk of Future Nasopharyngeal Cancer.
Chan KCA; Lam WKJ; King A; Lin VS; Lee PPH; Zee BCY; Chan SL; Tse IOL; Tsang AFC; Li MZJ; Jiang P; Ai QYH; Poon DMC; Au KH; Hui EP; Ma BBY; Van Hasselt AC; Chan ATC; Woo JKS; Lo YMD
NEJM Evid; 2023 Jul; 2(7):EVIDoa2200309. PubMed ID: 38320164
[TBL] [Abstract][Full Text] [Related]
20. Early detection of nasopharyngeal carcinoma: performance of a short contrast-free screening magnetic resonance imaging.
King AD; Ai QYH; Lam WKJ; Tse IOL; So TY; Wong LM; Tsang JYM; Leung HS; Zee BCY; Hui EP; Ma BBY; Vlantis AC; van Hasselt AC; Chan ATC; Woo JKS; Chan KCA
J Natl Cancer Inst; 2024 May; 116(5):665-672. PubMed ID: 38171488
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
